Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Biosimilar Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Biosimilar Drug market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilar Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Changchun High Tech
Biotech
Novartis
Celgen
Innovent
Eli Lilly
Amgen
CP Guojian
Henlius CP Guojian
By Type:
Tablets
Injection
Others
By End-User:
Cardiovascular
Rheumatoid Arthrtis
Tumor
Ankylosing Spondylitis
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilar Drug Market
-
1.3 Market Segment by Type
1.3.1 Japan Biosimilar Drug Market Size and Growth Rate of Tablets from 2014 to 2026
1.3.2 Japan Biosimilar Drug Market Size and Growth Rate of Injection from 2014 to 2026
1.3.3 Japan Biosimilar Drug Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Biosimilar Drug Market Size and Growth Rate of Cardiovascular from 2014 to 2026
1.4.2 Japan Biosimilar Drug Market Size and Growth Rate of Rheumatoid Arthrtis from 2014 to 2026
1.4.3 Japan Biosimilar Drug Market Size and Growth Rate of Tumor from 2014 to 2026
1.4.4 Japan Biosimilar Drug Market Size and Growth Rate of Ankylosing Spondylitis from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Biosimilar Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biosimilar Drug by Major Types
3.4.1 Market Size and Growth Rate of Tablets
3.4.2 Market Size and Growth Rate of Injection
3.4.3 Market Size and Growth Rate of Others
4 Segmentation of Biosimilar Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biosimilar Drug by Major End-Users
4.4.1 Market Size and Growth Rate of Biosimilar Drug in Cardiovascular
4.4.2 Market Size and Growth Rate of Biosimilar Drug in Rheumatoid Arthrtis
4.4.3 Market Size and Growth Rate of Biosimilar Drug in Tumor
4.4.4 Market Size and Growth Rate of Biosimilar Drug in Ankylosing Spondylitis
5 Market Analysis by Regions
-
5.1 Japan Biosimilar Drug Production Analysis by Regions
-
5.2 Japan Biosimilar Drug Consumption Analysis by Regions
6 Hokkaido Biosimilar Drug Landscape Analysis
-
6.1 Hokkaido Biosimilar Drug Landscape Analysis by Major Types
-
6.2 Hokkaido Biosimilar Drug Landscape Analysis by Major End-Users
7 Tohoku Biosimilar Drug Landscape Analysis
-
7.1 Tohoku Biosimilar Drug Landscape Analysis by Major Types
-
7.2 Tohoku Biosimilar Drug Landscape Analysis by Major End-Users
8 Kanto Biosimilar Drug Landscape Analysis
-
8.1 Kanto Biosimilar Drug Landscape Analysis by Major Types
-
8.2 Kanto Biosimilar Drug Landscape Analysis by Major End-Users
9 Chubu Biosimilar Drug Landscape Analysis
-
9.1 Chubu Biosimilar Drug Landscape Analysis by Major Types
-
9.2 Chubu Biosimilar Drug Landscape Analysis by Major End-Users
10 Kinki Biosimilar Drug Landscape Analysis
-
10.1 Kinki Biosimilar Drug Landscape Analysis by Major Types
-
10.2 Kinki Biosimilar Drug Landscape Analysis by Major End-Users
11 Chugoku Biosimilar Drug Landscape Analysis
-
11.1 Chugoku Biosimilar Drug Landscape Analysis by Major Types
-
11.2 Chugoku Biosimilar Drug Landscape Analysis by Major End-Users
12 Shikoku Biosimilar Drug Landscape Analysis
-
12.1 Shikoku Biosimilar Drug Landscape Analysis by Major Types
-
12.2 Shikoku Biosimilar Drug Landscape Analysis by Major End-Users
13 Kyushu Biosimilar Drug Landscape Analysis
-
13.1 Kyushu Biosimilar Drug Landscape Analysis by Major Types
-
13.2 Kyushu Biosimilar Drug Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Changchun High Tech
14.1.1 Changchun High Tech Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Biotech
14.2.1 Biotech Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Novartis
14.3.1 Novartis Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Celgen
14.4.1 Celgen Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Innovent
14.5.1 Innovent Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Eli Lilly
14.6.1 Eli Lilly Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Amgen
14.7.1 Amgen Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 CP Guojian
14.8.1 CP Guojian Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Henlius CP Guojian
14.9.1 Henlius CP Guojian Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
The List of Tables and Figures (Totals 111 Figures and 129 Tables)
Figure Japan Biosimilar Drug Market Size and Growth Rate of Tablets from 2014 to 2026
Figure Japan Biosimilar Drug Market Size and Growth Rate of Injection from 2014 to 2026
Figure Japan Biosimilar Drug Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Biosimilar Drug Market Size and Growth Rate of Cardiovascular from 2014 to 2026
Figure Japan Biosimilar Drug Market Size and Growth Rate of Rheumatoid Arthrtis from 2014 to 2026
Figure Japan Biosimilar Drug Market Size and Growth Rate of Tumor from 2014 to 2026
Figure Japan Biosimilar Drug Market Size and Growth Rate of Ankylosing Spondylitis from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Biosimilar Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Biosimilar Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Biosimilar Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biosimilar Drug by Different Types from 2014 to 2026
-
Table Consumption Share of Biosimilar Drug by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Tablets
Figure Market Size and Growth Rate of Injection
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Biosimilar Drug by Different End-Users from 2014 to 2026
-
Table Consumption Share of Biosimilar Drug by Different End-Users from 2014 to 2026
Figure Japan Biosimilar Drug Market Size and Growth Rate of Cardiovascular from 2014 to 2026
Figure Japan Biosimilar Drug Market Size and Growth Rate of Rheumatoid Arthrtis from 2014 to 2026
Figure Japan Biosimilar Drug Market Size and Growth Rate of Tumor from 2014 to 2026
Figure Japan Biosimilar Drug Market Size and Growth Rate of Ankylosing Spondylitis from 2014 to 2026
-
Table Japan Biosimilar Drug Production by Regions
-
Table Japan Biosimilar Drug Production Share by Regions
-
Figure Japan Biosimilar Drug Production Share by Regions in 2014
-
Figure Japan Biosimilar Drug Production Share by Regions in 2018
-
Figure Japan Biosimilar Drug Production Share by Regions in 2026
-
Table Japan Biosimilar Drug Consumption by Regions
-
Table Japan Biosimilar Drug Consumption Share by Regions
-
Figure Japan Biosimilar Drug Consumption Share by Regions in 2014
-
Figure Japan Biosimilar Drug Consumption Share by Regions in 2018
-
Figure Japan Biosimilar Drug Consumption Share by Regions in 2026
-
Table Hokkaido Biosimilar Drug Consumption by Types from 2014 to 2026
-
Table Hokkaido Biosimilar Drug Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Biosimilar Drug Consumption Share by Types in 2014
-
Figure Hokkaido Biosimilar Drug Consumption Share by Types in 2018
-
Figure Hokkaido Biosimilar Drug Consumption Share by Types in 2026
-
Table Hokkaido Biosimilar Drug Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Biosimilar Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Biosimilar Drug Consumption Share by End-Users in 2014
-
Figure Hokkaido Biosimilar Drug Consumption Share by End-Users in 2018
-
Figure Hokkaido Biosimilar Drug Consumption Share by End-Users in 2026
-
Table Tohoku Biosimilar Drug Consumption by Types from 2014 to 2026
-
Table Tohoku Biosimilar Drug Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Biosimilar Drug Consumption Share by Types in 2014
-
Figure Tohoku Biosimilar Drug Consumption Share by Types in 2018
-
Figure Tohoku Biosimilar Drug Consumption Share by Types in 2026
-
Table Tohoku Biosimilar Drug Consumption by End-Users from 2014 to 2026
-
Table Tohoku Biosimilar Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Biosimilar Drug Consumption Share by End-Users in 2014
-
Figure Tohoku Biosimilar Drug Consumption Share by End-Users in 2018
-
Figure Tohoku Biosimilar Drug Consumption Share by End-Users in 2026
-
Table Kanto Biosimilar Drug Consumption by Types from 2014 to 2026
-
Table Kanto Biosimilar Drug Consumption Share by Types from 2014 to 2026
-
Figure Kanto Biosimilar Drug Consumption Share by Types in 2014
-
Figure Kanto Biosimilar Drug Consumption Share by Types in 2018
-
Figure Kanto Biosimilar Drug Consumption Share by Types in 2026
-
Table Kanto Biosimilar Drug Consumption by End-Users from 2014 to 2026
-
Table Kanto Biosimilar Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Biosimilar Drug Consumption Share by End-Users in 2014
-
Figure Kanto Biosimilar Drug Consumption Share by End-Users in 2018
-
Figure Kanto Biosimilar Drug Consumption Share by End-Users in 2026
-
Table Chubu Biosimilar Drug Consumption by Types from 2014 to 2026
-
Table Chubu Biosimilar Drug Consumption Share by Types from 2014 to 2026
-
Figure Chubu Biosimilar Drug Consumption Share by Types in 2014
-
Figure Chubu Biosimilar Drug Consumption Share by Types in 2018
-
Figure Chubu Biosimilar Drug Consumption Share by Types in 2026
-
Table Chubu Biosimilar Drug Consumption by End-Users from 2014 to 2026
-
Table Chubu Biosimilar Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Biosimilar Drug Consumption Share by End-Users in 2014
-
Figure Chubu Biosimilar Drug Consumption Share by End-Users in 2018
-
Figure Chubu Biosimilar Drug Consumption Share by End-Users in 2026
-
Table Kinki Biosimilar Drug Consumption by Types from 2014 to 2026
-
Table Kinki Biosimilar Drug Consumption Share by Types from 2014 to 2026
-
Figure Kinki Biosimilar Drug Consumption Share by Types in 2014
-
Figure Kinki Biosimilar Drug Consumption Share by Types in 2018
-
Figure Kinki Biosimilar Drug Consumption Share by Types in 2026
-
Table Kinki Biosimilar Drug Consumption by End-Users from 2014 to 2026
-
Table Kinki Biosimilar Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Biosimilar Drug Consumption Share by End-Users in 2014
-
Figure Kinki Biosimilar Drug Consumption Share by End-Users in 2018
-
Figure Kinki Biosimilar Drug Consumption Share by End-Users in 2026
-
Table Chugoku Biosimilar Drug Consumption by Types from 2014 to 2026
-
Table Chugoku Biosimilar Drug Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Biosimilar Drug Consumption Share by Types in 2014
-
Figure Chugoku Biosimilar Drug Consumption Share by Types in 2018
-
Figure Chugoku Biosimilar Drug Consumption Share by Types in 2026
-
Table Chugoku Biosimilar Drug Consumption by End-Users from 2014 to 2026
-
Table Chugoku Biosimilar Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Biosimilar Drug Consumption Share by End-Users in 2014
-
Figure Chugoku Biosimilar Drug Consumption Share by End-Users in 2018
-
Figure Chugoku Biosimilar Drug Consumption Share by End-Users in 2026
-
Table Shikoku Biosimilar Drug Consumption by Types from 2014 to 2026
-
Table Shikoku Biosimilar Drug Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Biosimilar Drug Consumption Share by Types in 2014
-
Figure Shikoku Biosimilar Drug Consumption Share by Types in 2018
-
Figure Shikoku Biosimilar Drug Consumption Share by Types in 2026
-
Table Shikoku Biosimilar Drug Consumption by End-Users from 2014 to 2026
-
Table Shikoku Biosimilar Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Biosimilar Drug Consumption Share by End-Users in 2014
-
Figure Shikoku Biosimilar Drug Consumption Share by End-Users in 2018
-
Figure Shikoku Biosimilar Drug Consumption Share by End-Users in 2026
-
Table Kyushu Biosimilar Drug Consumption by Types from 2014 to 2026
-
Table Kyushu Biosimilar Drug Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Biosimilar Drug Consumption Share by Types in 2014
-
Figure Kyushu Biosimilar Drug Consumption Share by Types in 2018
-
Figure Kyushu Biosimilar Drug Consumption Share by Types in 2026
-
Table Kyushu Biosimilar Drug Consumption by End-Users from 2014 to 2026
-
Table Kyushu Biosimilar Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Biosimilar Drug Consumption Share by End-Users in 2014
-
Figure Kyushu Biosimilar Drug Consumption Share by End-Users in 2018
-
Figure Kyushu Biosimilar Drug Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Changchun High Tech
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun High Tech
Figure Sales and Growth Rate Analysis of Changchun High Tech
Figure Revenue and Market Share Analysis of Changchun High Tech
Table Product and Service Introduction of Changchun High Tech
Table Company Profile and Development Status of Biotech
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotech
Figure Sales and Growth Rate Analysis of Biotech
Figure Revenue and Market Share Analysis of Biotech
Table Product and Service Introduction of Biotech
Table Company Profile and Development Status of Novartis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
Figure Sales and Growth Rate Analysis of Novartis
Figure Revenue and Market Share Analysis of Novartis
Table Product and Service Introduction of Novartis
Table Company Profile and Development Status of Celgen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgen
Figure Sales and Growth Rate Analysis of Celgen
Figure Revenue and Market Share Analysis of Celgen
Table Product and Service Introduction of Celgen
Table Company Profile and Development Status of Innovent
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innovent
Figure Sales and Growth Rate Analysis of Innovent
Figure Revenue and Market Share Analysis of Innovent
Table Product and Service Introduction of Innovent
Table Company Profile and Development Status of Eli Lilly
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
Figure Sales and Growth Rate Analysis of Eli Lilly
Figure Revenue and Market Share Analysis of Eli Lilly
Table Product and Service Introduction of Eli Lilly
Table Company Profile and Development Status of Amgen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
Figure Sales and Growth Rate Analysis of Amgen
Figure Revenue and Market Share Analysis of Amgen
Table Product and Service Introduction of Amgen
Table Company Profile and Development Status of CP Guojian
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CP Guojian
Figure Sales and Growth Rate Analysis of CP Guojian
Figure Revenue and Market Share Analysis of CP Guojian
Table Product and Service Introduction of CP Guojian
Table Company Profile and Development Status of Henlius CP Guojian
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Henlius CP Guojian
Figure Sales and Growth Rate Analysis of Henlius CP Guojian
Figure Revenue and Market Share Analysis of Henlius CP Guojian
Table Product and Service Introduction of Henlius CP Guojian
-
